cAMP accumulation assay

YB Yu Bai
XZ Xin Zhang
JZ Jie Zheng
ZL Ziyi Liu
ZY Zhenfan Yang
XZ Xiaolin Zhang
ask Ask a question
Favorite

Assays were performed with HTRF cAMP kit (Cisbio, 62AM4PEJ). A series dilution of compound (11 concentrations of compound, starting at 10 µM, 4-fold dilutions) was added into 384-well plates prior to cell seeding and DMSO was added to the control well. CHO-A2aR and CHO-A2bR cells were seeded in the plates at a density of 5,000 cells/well in F-12 medium containing 10% FBS. Plates were incubated at 37˚C for 30 min, then DMSO (control), adenosine (1, 10, and 100 µM), or NECA (0.1, 1, and 10 µM) were added to cells and further incubated at 37˚C 30 min. cAMP signal was measured on Envision (Perkin Elmer). The concentration of compound producing 50% inhibition of the cAMP (IC50) was calculated using four-parameter logistic fit with XLFIT. The dose-response curves were fitted by nonlinear regression using GraphPad Prism.

NECA is a stable analogue of adenosine commonly used to measure adenosine pathway activity. Consistent with the trend in binding affinity to A2aR [31], NECA was also more potent than adenosine in stimulating cAMP accumulation via A2aR, approximately 10-fold stronger (Supplemental Fig. S1).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A